GLP-1 Receptor Agonist Market to Surpass $ 19,253.8 Million Growing at a CAGR 6.1% | GlaxoSmithKline plc, Novo Nordisk A/S, PegBio Co., Ltd

GLP-1 receptor (Glucagon like peptide-1 receptor) is a receptor protein found in the neurons of the brain and the beta cells of pancreas. GLP-1 receptor is involved in regulating the process of insulin secretion in the body. GLP-1 and glucagon are the natural endogenous agonists of GLP-1 receptor. An agonist is a chemical entity which induces a biological response by binding to a receptor and activating it. Some of the other agonists of GLP-1 receptor include exenatide, lixisenatide, albiglutide, liraglutide, dulaglutide, and semaglutide. GLP-1 receptor agonists are commonly used for the treatment of diabetes and obesity. When an agonist binds to the GLP-1 receptor the receptor becomes activated and results in stimulation of adenylyl cyclase pathway.

The global GLP-1 receptor agonist market is estimated to be valued at US$ 12,720.6 million in 2021 and is expected to exhibit a CAGR of 6.1% over the forecast period (2021-2028).

Request Here Sample + 360 Pages PDF, All Related Graphs of this Report @: https://www.coherentmarketinsights.com/insight/request-sample/4632

Adenylyl cyclase pathway leads to increased production and release of insulin in the beta cells of pancreas. GLP-1 receptors expressed in the brain neurons are responsible for controlling appetite. GLP-1 receptor is also expressed in stretch responsive sensory neurons of the stomach and intestines. These GLP-1 receptor neurons, when activated can cause changes in the breathing and heart rate. GLP-1 receptor agonists, also known as incretin mimetics, are advantageous over traditional insulin secretagogues, such as sulfonylureas or meglitinides as they pose a low risk of causing hypoglycemia or low blood sugar.

The increasing incidence of diabetes and obesity, rising research and development activities for the development of novel therapeutics for the treatment of diabetes and obesity, and increasing adoption of inorganic growth strategies such as merger, acquisitions, distributive agreements, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global GLP-1 receptor agonist market over the forecast period.

For instance, according to the Pan American Journal of Public Health, the number of people living with type 1 diabetes in the Americas is expected to increase from 35 million in 2000 to 64 million in 2025, out of which Latin America and Caribbean region would account for 62% or 40 million people in 2025.

Get Discount On The Purchase Of This Report @
https://www.coherentmarketinsights.com/promo/buynow/4632

Table of Contents

-- Report Overview: It includes the GLP-1 Receptor Agonist market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

-- Executive Summary: This section of the report gives information about GLP-1 Receptor Agonist market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

-- Profiles of International Players: Here, key players of the GLP-1 Receptor Agonist market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

-- Regional Study: All of the regions and countries analyzed in the GLP-1 Receptor Agonist market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Inquire more about this report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/4632

Key Benefits:

• This study gives a detailed analysis of drivers and factors limiting the market expansion of GLP-1 Receptor Agonist

• The micro-level analysis is conducted based on its product types, end-user applications, and geographies

• Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

• By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this GLP-1 Receptor Agonist market

The research study can answer the following Key questions:

• What will be the progress rate of the GLP-1 Receptor Agonist Market for the conjecture period, 2021-2028?

• What are the prominent factors driving the GLP-1 Receptor Agonist Market across different regions?

• Who are the major vendors dominating the GLP-1 Receptor Agonist industry and what are their winning strategies?

• What will be the market scope for the estimated period?

• What are the major trends shaping the expansion of the industry in the coming years?

• What are the challenges faced by the GLP-1 Receptor Agonist Market?

Read Detailed Index of Full Research Study at @
https://www.coherentmarketinsights.com/market-insight/glp-1-receptor-agonist-market-4632

Our analysts are experts in this field with years of experience. We at Coherent Market Insights maintain the highest level of accuracy and transparency in the report. The primary and secondary resources used in the report are taken from reliable and high authority sources to deliver 100% accurate and trusted data.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Oceania, LATAM, South America, NORDIC, West Europe, Europe or Southeast Asia.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Author:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunities.

This release was published on openPR.